David W. Crabb, Director at BIOANALYTICAL SYSTEMS INC (BASI), bought 1,300 shares at $0.80 ($1K) on 2010-02-22, disclosed to the SEC on 2010-02-23.
Open-market purchase of $1k BASI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.